Suppr超能文献

凝集素样氧化型低密度脂蛋白受体-1 将热休克蛋白 60 融合抗原递呈到 MHC Ⅰ类途径。

Lectin-like oxidized low-density lipoprotein receptor-1 delivers heat shock protein 60-fused antigen into the MHC class I presentation pathway.

机构信息

Gene Research Center, Institutes of Biomedical Science, Shanghai Medical College, Fudan University, Shanghai, China.

出版信息

J Immunol. 2010 Aug 15;185(4):2306-13. doi: 10.4049/jimmunol.0903214. Epub 2010 Jul 14.

Abstract

Heat shock protein (Hsp) 60 elicits a potent proinflammatory response in the innate immune system and has been proposed as a danger signal of stressed or damaged cells to the immune system. Previous studies reported CD14, TLR2, and TLR4 as mediators of signaling but probably not of binding. Although the receptor for Hsp60 was proposed to be saturable and specific on macrophages, it is not well defined. In the current study, we found that lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), as a receptor for Hsp60, could bind and internalize Hsp60 via the C terminus of Hsp60. Yeast two-hybrid assay revealed that the second beta-sheet containing the long-loop region of LOX-1 played an important role in this interaction. Furthermore, LOX-1 might be engaged as a common receptor for different Hsp60 species. Bone marrow-derived dendritic cells could cross-present Hsp60-fused OVA Ag on MHC class I molecules via LOX-1. Inhibition of the recognition of Hsp60 by LOX-1 decreases Hsp60-mediated cross-presentation of OVA and specific CTL response and protective tumor immunity in vivo. Taken together, these results demonstrate that LOX-1 functions as a receptor for Hsp60 and is involved in the delivery of Hsp60-fused Ag into the MHC class I presentation pathway.

摘要

热休克蛋白 (Hsp) 60 在内源性免疫系统中引发强烈的促炎反应,并被认为是应激或受损细胞向免疫系统发出的危险信号。先前的研究报告称 CD14、TLR2 和 TLR4 是信号转导的介质,但可能不是结合的介质。尽管 Hsp60 的受体在巨噬细胞上被认为是饱和和特异的,但它的定义并不明确。在本研究中,我们发现凝集素样氧化型低密度脂蛋白受体-1 (LOX-1) 作为 Hsp60 的受体,可以通过 Hsp60 的 C 端结合和内化 Hsp60。酵母双杂交试验表明,LOX-1 中含有长环区域的第二个β-折叠在这种相互作用中起着重要作用。此外,LOX-1 可能作为不同 Hsp60 物种的共同受体参与。骨髓来源的树突状细胞可以通过 LOX-1 在 MHC I 类分子上交叉呈递 Hsp60 融合的 OVA Ag。抑制 LOX-1 对 Hsp60 的识别可降低 Hsp60 介导的 OVA 交叉呈递和特异性 CTL 反应,并降低体内保护性肿瘤免疫。总之,这些结果表明 LOX-1 作为 Hsp60 的受体发挥作用,并参与将 Hsp60 融合 Ag 递送至 MHC I 类呈递途径。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验